Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
383.00    2.00 (0.52%)
Bid:
378.00
Ask:
384.50
Spread: 6.50 (1.72%)
Market Cap: £1.96b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

3 Jun 2026 17:08

RNS Number : 9012G
Caledonia Investments PLC
03 June 2026
 

 

Caledonia Investments plc

 

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

 

Pursuant to the requirements of the UK Market Abuse Regulation ("MAR"), Caledonia Investments plc ("Caledonia" or the "Company") announces that on 29 May 2026 the following nil-cost options over ordinary 0.5p shares in Caledonia were granted to executive directors under the Caledonia Investments 2020 Performance Share Scheme (the "PSS") and in respect of compulsory deferral of bonus under the Caledonia Investments 2020 Deferred Bonus Plan (the "DBP"). The Company's share price used to determine the number of PSS awards and DBP awards was 363.5p.

 

Executive Director

No. of shares over which PSS nil-cost options granted

No. of shares over which DBP nil-cost options granted

J M B Cayzer-Colvin

176,245

 14,257

M S D Masters

223,164

 20,220

R W Memmott

192,256

 17,420

 

Subject to the rules of the PSS, nil-cost options are exercisable between three and ten years after the date of grant. Performance is measured over three years for one-third of the PSS awards which are subject to a post-vesting holding period, on an after-tax basis, of two years. The remaining two-thirds of the awards are subject to performance over five years.

 

Subject to the rules of the DBP, deferred share awards vest after a three-year retention period.

 

The total number of shares held under option by the above-named executive directors of Caledonia under the Company's share schemes following these nil-cost option grants are as follows:

 

Executive Director

Total no. of shares held under option under performance share schemes

Total no. of shares held under option under the DBP

J M B Cayzer-Colvin

1,094,862

29,137

M S D Masters

1,007,522

56,740

R W Memmott

715,634

23,410

 

Further information required by MAR in relation to these transactions is set out in the appendix below.

 

Enquiries:

Richard Webster

Company Secretary

Tel: + 44 20 7802 8080

 

3 June 2026

 

APPENDIX

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

James Michael Beale Cayzer-Colvin

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 0.5p shares

 

 

 

GB00BTNQ8K38

b)

 

Nature of the transaction

 

 

Grant of nil-cost options over ordinary 0.5p shares under:

(1) the Caledonia Investments 2020 Performance Share Scheme ("PSS")

 

(2) the Caledonia Investments 2020 Deferred Bonus Plan ("DBP")

 

c)

 

Price(s) and volume(s)

 

 

 

Description

Price(s)

 

Volume(s)

Grant of PSS award

 

£0.00

 

176,245

Grant of DBP award

 

£0.00

14,257

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

190,502

 

Nil

e)

 

Date of the transaction

 

29 May 2026

f)

Place of the transaction

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Mathew Simon Dexter Masters

2

 

Reason for the notification

 

a)

 

Position/status

 

Director/Chief Executive Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 0.5p shares

 

 

 

GB00BTNQ8K38

b)

 

Nature of the transaction

 

 

Grant of nil-cost options over ordinary 5p shares under:

 

(1) the Caledonia Investments 2020 Performance Share Scheme ("PSS")

 

(2) the Caledonia Investments 2020 Deferred Bonus Plan ("DBP")

 

c)

 

Price(s) and volume(s)

 

 

 

 

Description

Price(s)

 

Volume(s)

Grant of PSS award

 

£0.00

 

223,164

Grant of DBP award

 

£0.00

20,220

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

243,384

 

Nil

e)

 

Date of the transaction

 

29 May 2026

f)

Place of the transaction

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Robert William Memmott

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director/Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 0.5p shares

 

 

 

GB00BTNQ8K38

b)

 

Nature of the transaction

 

 

Grant of nil-cost options over ordinary 5p shares under:

 

(1) the Caledonia Investments 2020 Performance Share Scheme ("PSS")

 

(2) the Caledonia Investments 2020 Deferred Bonus Plan ("DBP")

 

c)

 

Price(s) and volume(s)

 

 

 

 

Description

Price(s)

 

Volume(s)

Grant of PSS award

 

£0.00

 

192,256

Grant of DBP award

 

£0.00

17,420

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

209,676

 

Nil

e)

 

Date of the transaction

 

29 May 2026

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBLGDLRGGDGLX
Date   Source Headline
29th Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20251:36 pmRNSDirector/PDMR Shareholding
9th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 202511:00 amRNSNet Asset Value(s)
3rd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTotal Voting Rights
28th Nov 20255:04 pmRNSDirector/PDMR Shareholding
28th Nov 20252:51 pmRNSDirector/PDMR Shareholding
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 202512:42 pmRNSIrrevocable Share Repurchase Instruction
25th Nov 20257:00 amRNSHalf-year Financial Report
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSNotice of half-year results
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20254:21 pmRNSHolding(s) in Company
14th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20251:27 pmRNSNet Asset Value(s)
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20257:00 amRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20254:08 pmRNSDirector/PDMR Shareholding
27th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:00 amRNSTransaction in Own Shares
7th Oct 20257:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.